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In Brief
Downstream of Cdc42, the atypical
protein kinase C (aPKC) is thought to be
the main effector at the apical domain.
Aguilar-Aragon et al. identify a second
kinase, Pak1, as being an additional
essential effector downstream of Cdc42
at the apical domain in both Drosophila
and mammalian epithelial cells.
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Epithelial cells are polarized along their apical-basal
axis by the action of the small GTPase Cdc42, which
is known to activate the aPKC kinase at the apical
domain. However, loss of aPKC kinase activity
was reported to have only mild effects on epithelial
cell polarity. Here, we show that Cdc42 also acti-
vates a second kinase, Pak1, to specify apical
domain identity in Drosophila and mammalian
epithelia. aPKC and Pak1 phosphorylate an overlap-
ping set of polarity substrates in kinase assays.
Inactivating both aPKC kinase activity and the
Pak1 kinase leads to a complete loss of epithelial
polarity and morphology, with cells losing markers
of apical polarization such as Crumbs, Par3/
Bazooka, or ZO-1. This function of Pak1 down-
stream of Cdc42 is distinct from its role in regu-
lating integrins or E-cadherin. Our results define a
conserved dual-kinase mechanism for the control
of apical membrane identity in epithelia.INTRODUCTION
Epithelial tissues make up much of the human body, forming
layers and tubes that separate the internal cavities of the
body from the external environment. Epithelial tissues also
are the site of origin for most human cancers, and progression
of tumors to malignancy involves disruption of epithelial
morphology. Epithelial cells exhibit polarization along their api-
cal-basal axis, which is essential for both the form and function
of the epithelium. How epithelial cell polarity is orchestrated at
the molecular level, and how it may become disrupted in hu-
man cancer is still poorly understood (Harris et al., 2009; Mac-
ara and McCaffrey, 2013; Martin-Belmonte and Perez-Moreno,
2011; St Johnston and Ahringer, 2010; Wirtz-Peitz and Zallen,
2009).
Pioneering genetic studies in model organisms such as the
budding yeastSaccharomyces cerevisiae, the wormCaenorhab-
ditis elegans, and the fruit flyDrosophilamelanogaster have iden-
tified a set of cell polarity determinants that are essential for the
polarization of all other molecules, organelles, and cytoskeletalCell Re
This is an open access article undelements in the cell (Thompson, 2013). In particular, the small
GTP-binding protein (GTPase) Cdc42 is a key regulator of cell
polarity in many species. In epithelial cells, Cdc42 forms a com-
plex with Par6 and the kinase aPKC (Garrard et al., 2003; Genova
et al., 2000; Hutterer et al., 2004; Joberty et al., 2000; Ohno,
2001; Peterson et al., 2004; Petronczki and Knoblich, 2001;
Wodarz et al., 2000; Yamanaka et al., 2001) that is recruited to
the plasma membrane by either Bazooka (Baz/Par3) or the
Crumbs (Crb) complex (Crb-Sdt/PALS1-PALS1-associated tight
junction [PATJ]) to define the apical membrane domain (Benton
and St Johnston, 2003; Fletcher et al., 2012; Hurd et al., 2003;
Joberty et al., 2000; Penkert et al., 2004; Tanentzapf and Tepass,
2003). Null mutants in either cdc42, par6, or aPKC result in a
complete loss of the apical domain and consequent rounding
up and extrusion of cells in Drosophila epithelia (Fletcher et al.,
2012; Hutterer et al., 2004; Petronczki and Knoblich, 2001; Rolls
et al., 2003; Wodarz et al., 2000); however, recent work demon-
strated that kinase-impairedmutants in aPKC did not completely
disrupt apical-basal polarity in Drosophila epithelia (Kim et al.,
2009) (Figure S1). This surprising finding suggests that aPKC
has an essential scaffold function, whereas its kinase activity is
non-essential.
Here, we show that apical membrane identity also requires
Pak1 kinase activity, in addition to aPKC kinase activity, down-
stream of Cdc42. This is a distinct function for Pak1 from its pre-
viously reported roles in regulating integrins or E-cadherin (Con-
der et al., 2007; del Pozo et al., 2000; Dummler et al., 2009;
Harden et al., 1996; Lucanic and Cheng, 2008; Pirraglia et al.,
2010; Santiago-Medina et al., 2013; Tomar and Schlaepfer,
2010). Pak1 appears to function similarly to aPKC, phosphory-
lating an overlapping set of targets and acting in a genetically
semiredundant fashion. These findings clarify how apical domain
identity is defined in epithelial cells.
RESULTS AND DISCUSSION
We sought to identify additional effectors of Cdc42 that may
mediate its function in specifying apical domain identity in
epithelial cells. We systematically examined the epithelial loss-
of-function phenotype of several alternative Cdc42 effectors.
These effectors included the actin nucleatingWasp-Arp2/3 com-
plex; the myotonic dystrophy-related Cdc42-binding kinase
(MRCK) or Genghis Khan (Gek) in Drosophila; and the kinases
Pak1, Pak3, and Pak4. Silencing expression of these effectorsports 22, 1639–1646, February 13, 2018 ª 2018 The Authors. 1639
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. An RNAi Screen for Cdc42 Effectors Contributing to Epithelial Polarization Identifies Pak1
(A) RNAi knockdown of Wasp-Arp2/3 complex, Pak3, Pak4, or MRCK/Gek does not have polarity phenotype, whereas Pak1 knockdown causes a partial
epithelial polarity disruption.
(B) The cdc423mutant phenotype is similar to but stronger than that of Pak1 loss of function. Note that RNAi knockdown of Pak1 or induction of pak114 null mutant
clones throughout the epithelium causes a mild disruption of aPKC.
(C) Pak1-GFP is recruited to the plasma membrane by active Cdc42. Coexpression of Cdc42V12 with Pak1-GFP results in translocation of Pak1-GFP from
cytoplasmic punctae to the plasma membrane.
(D) Epithelial polarity is not affected in follicle cells expressing RNAi against b-integrins (mys) or in the triple Rac mutant (rac1, rac2, mtl).by RNAi in the Drosophila follicular epithelium had no effect on
epithelial polarity, except in the case of the kinase Pak1, whose
knockdown caused a mild polarity phenotype (Figure 1A). We
examined the phenotype of pak1 null mutant clones in follicle
cells, which precisely phenocopied the RNAi knockdown pheno-
type, producing a mild disruption of epithelial polarity reminis-
cent of a mild cdc42 loss of function (Figure 1B). We validated
the RNAi screen using mutant clones for each gene or, in the
case of Pak3, an additional previously validated RNAi line (Felix
et al., 2015) (Figures S2A and S2B). This result suggests that
Cdc42 may activate Pak1 kinase activity to maintain apical
identity in epithelial cells. In support of this view, expression of
a constitutively active form of Cdc42 (V12) is sufficient to drive
recruitment of Pak1-GFP to the plasma membrane, along with
the aPKC kinase (Figure 1C).1640 Cell Reports 22, 1639–1646, February 13, 2018We note that Pak1 is well known to act as an effector of Rac
and Cdc42 in basal integrin-Src signaling for cell migration (del
Pozo et al., 2000; Dummler et al., 2009; Lucanic and Cheng,
2008; Santiago-Medina et al., 2013; Tomar and Schlaepfer,
2010); it also affects basal F-actin bundles in Drosophila epithe-
lial cells (Conder et al., 2007; Harden et al., 1996). However, the
role of Pak1 at the apical domain of epithelial cells is not a conse-
quence of disruption of basal integrins or integrin-Rac signaling,
because the loss of b-integrin (myospheroid [mys]) or the
absence of all three Rac genes (rac1, rac2, mtl) (Hakeda-Suzuki
et al., 2002; Ng et al., 2002) does not affect epithelial polarity in
Drosophila (Figures 1D and S2C). Pak1 also has been implicated
in regulating E-cadherin endocytosis to control lumen size (Pirra-
glia et al., 2010), but this role cannot account for the function that
we observe in maintaining apical identity.
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Figure 2. aPKC and Pak1 Act Redundantly to Maintain Apical Domain Identity
(A–C) aPKC (A), Crb-GFP (B), and Baz/Par3 (C) localize apically in control follicle cells treated with DMSO, but are partially lost upon treatment with either aPKC
kinase inhibitors or Pak1 kinase inhibitors, and are completely lost upon treatment with both inhibitors.
(D) aPKC localizes apically in control follicle cells, is partially lost in aPKCpsu265mutant follicle cells or upon RNAi knockdown of Pak1, and is completely lost upon
RNAi knockdown of Pak1 in aPKCpsu265 mutant follicle cells.
(E) RNAi knockdown of Pak1 in aPKCpsu265 mutant follicle cells (GFP+ cells) causes the loss of aPKC from the apical domain and the ectopic spreading
of Dlg.
(F) RNAi knockdown of Pak1 in myr-Lgl-GFP expressing follicle cells (an inhibitor of aPKC kinase) causes the loss of aPKC from the apical domain.We reasoned that Cdc42 may function by activating both the
aPKC kinase and the Pak1 kinase at the apical domain to specify
apical identity. If the two kinases acted in a redundant fashion,
then it would explain why inactivating either aPKC kinase activity
or Pak1 activity fails to completely disrupt epithelial polarity. To
examine this possibility, we treated follicle cells with highly spe-
cific kinase inhibitors for both aPKC and Pak1 (Deacon et al.,
2008; Kjær et al., 2013; Rodriguez et al., 2017), which, when
used together, are able to disrupt the apical plasma membrane
domain (Figures 2A–C). Note that Pak1 or aPKC inhibitor treat-
ment does not cause increased phenotypic severity in Pak1-
RNAi expressing cells or aPKC kinase-impaired clones, respec-
tively (Figures S2D and S2E). To confirm the synergy between
loss of aPKC and Pak1 kinase activity, we compared the
phenotypes of aPKC kinase-impaired mutant cells alone with
aPKC kinase-impaired mutant cells in which pak1 expression
was silenced by RNAi. We find that the loss of Pak1 dramatically
enhanced the aPKC kinase-impaired mutant phenotype, result-
ing in a complete loss of the apical plasma membrane domain
and flattening of cell morphology (Figure 2D).WhenGFP-marked
clones of cells lacking both aPKC kinase activity and Pak1 kinase
were induced, the apical domain was disrupted cell autono-
mously within the clone, whereas the basolateral domain spread
around the entire plasmamembrane within the clone (Figure 2E).
We confirmed these findings by overexpressing myr-Lgl-GFP, amembrane-associated form of Lgl that was previously shown to
be an aPKC kinase inhibitor (Bell et al., 2015), with and without
Pak1-RNAi (Figure 2F). The myr-Lgl-GFP phenotype resembles
the aPKC kinase-impaired phenotype, alone or when expressed
together with Pak1-RNAi (Figure 2F). These results demonstrate
that aPKC kinase activity and Pak1 kinase activity act semi-
redundantly downstream of Cdc42 to maintain epithelial cell po-
larity in the ovaries of Drosophila.
We next considered how aPKC and Pak1 may act in a
redundant fashion. We note that aPKC and Pak1 have similar
consensus sites (Rennefahrt et al., 2007), and we found that
Pak1 can act upon many aPKC targets in kinase assays,
including Crb, Baz, Par6, and Lgl (Figure 3A). To confirm these
findings in vivo, we examined phosphorylation of Baz with an
anti-p-Baz antibody, and found that staining is reduced only
upon inhibition of both aPKC and Pak1 kinases (Figure 3B). We
also examined a GFP-tagged form of the Lgl substrate, which
is known to be excluded from the apical domain of epithelial cells
by phosphorylation on its lipid-binding motif (Figure 3C). Treat-
ment with the aPKC inhibitor drug fails to cause apical localiza-
tion of Lgl-GFP, as does treatment with the Pak1 inhibitor alone,
but the combination of aPKC and Pak1 inhibitors was able to
relocalize Lgl to the apical domain (Figure 3C). These results
support the notion that both aPKC and Pak1 can act in parallel
to phosphorylate an overlapping set of substrates.Cell Reports 22, 1639–1646, February 13, 2018 1641
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Figure 3. aPKC and Pak1 Both Contribute to Phosphorylation of Known aPKC Targets Such as Baz and Lgl
(A) Consensus motifs for aPKC and Pak1 are similar, and both kinase domains (KDs; top) can phosphorylate known aPKC targets (Crb, Par6, Baz/Par3, Lgl)
in vitro (bottom).
(B) Phospho-Baz (p-Baz) staining of UAS.Baz-GFP expressing follicular epithelia in the presence of aPKC inhibitor, Pak1 inhibitor, or both. Note that loss of p-Baz
requires inhibition of both kinases.
(C) Lgl localization in UAS.Lgl-GFP expressing follicular epithelia in the presence of aPKC inhibitor, Pak1 inhibitor, or both. Note that apical localization of Lgl
requires inhibition of both kinases.Finally, we examined whether our findings in Drosophila were
conserved in mammalian epithelial cells. In support of this idea,
both aPKC isoforms (iota and zeta) and Pak1 localized similarly
to the apical domain of human intestinal epithelial cells (Fig-
ure 4A). We found that treatment with aPKC and Pak1 inhibitors
completely disrupted the ability of epithelial cells to form
proper polarized structures in mouse intestinal organoids, hu-
man Caco2 intestinal cells, and canine kidney epithelial cells
(MDCK), both cultured in 3D (Figures 4B, 4C, and S4). We further
cultured Caco2 cells in 2D, where we found that small interfering
RNA (siRNA) silencing Cdc42 expression or both aPKC and
Pak1 expression disrupts epithelial integrity as marked by
the continuous localization of ZO-1 in an apical ring (Figures
4D–4F). The aPKC and Pak1 siRNA phenotype can be rescued
by overexpression of cDNA against Pak1 or aPKC, respectively
(Figures S3A and S3B). Treatment with aPKC and Pak1 inhibi-
tors disrupts the localization of ZO-1 in the same fashion (Fig-
ures 4G, S3C, and S3D). These results indicate that the system
we have uncovered in Drosophila has a conserved and funda-
mental role in maintaining epithelial cell polarity in mammalian
epithelia.1642 Cell Reports 22, 1639–1646, February 13, 2018Our findings reveal that Cdc42 acts to polarize the apical
domain of epithelial cells via two kinases: aPKC and Pak1.
We note a striking analogy with Cdc42 function in the yeast
S. cerevisiae, where it also acts via two Pak-family kinases:
Ste20 and Cla4. Thus, Pak kinase activation appears to be the
ancestral function for Cdc42 GTPases in eukaryotes, whereas
aPKCactivationmay have evolved later inmetazoans to diversify
Cdc42 function. Our data show that both kinases contribute to
the polarization of epithelial cells, and we find that chemically in-
hibiting both aPKC and Pak1 disrupts epithelial polarity in human
epithelial cells in a manner that resembles the progression of
adenocarcinomas. Thus, our results indicate that loss of apical
domain identity could be a critical contributor to the progression
of epithelial cancers.EXPERIMENTAL PROCEDURES
Mitotic clones in follicle cells were generated using the FLP (Flipase)/FRT
(Flipase recombination target) system andweremarked either positively (pres-
ence of GFP; MARCM) or negatively (absence of GFP). Third instar larvae were
heat shocked once for 1 hr at 37C and dissected 3 days after eclosion.
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Figure 4. Requirement for aPKC and Pak1 Kinases in Mammalian Colonic Epithelial Cell Polarity
(A) Schematic diagram of aPKC and Pak1 activation by Cdc42. Note that two aPKC zeta/iota homologs and Pak1 localize apically in human colonic epithelia.
(B) Mouse intestinal organoids grown in Matrigel and treated with both aPKC and Pak1 inhibitors exhibit loss of epithelial polarity more strongly in the double
treatments than in the single treatments.
(C) aPKC and Pak 1 inhibitor treatment in 3D Caco-2 cultures results in disorganized Caco-2 epithelial cysts.
(D) Cdc42 siRNA in 2D plated Caco-2 cells results in a strong disruption of the apical marker ZO-1.
(E) Double siRNA of aPKC and Pak1 results in a much stronger effect on ZO-1 than single knockdowns in Caco-2 cells, thus mimicking Cdc42 depletion.
(F) Quantification of the effect of various siRNA treatments on the organization of ZO-1 and immunoblots showing the efficiency of the Pak1 and aPKC
knockdowns in Caco-2 cells.
(G) aPKC and Pak 1 inhibitor phenocopies siRNA treatment in 2D Caco-2 cultures.Expression of upstream activation sequence (UAS) transgenic lines was
achieved with the tj.Gal4 line, the actin ‘‘flip-out’’ system, and the MARCM
system. For ‘‘flip-out’’ clones, third instar larvae were heat shocked at 37C
for 20 min and dissected 3 days after eclosion.
Immunostaining of Ovaries
Ovaries were dissected in PBS, fixed for 20 min in 4% paraformaldehyde
in PBS, washed for 30 min in PBS/0.1% Triton X-100 (PBT), and blocked for15 min in 5% normal goat serum (NGS)/PBT. Primary antibodies were diluted
in NGS/PBT and samples were incubated overnight at 4C. Secondary anti-
bodies were used for 2 hr at room temperature and then mounted on slides
in Vectashield (Vector Laboratories). Images were taken with a Leica SP5
confocal microscope and processed with Adobe Photoshop.
The primary antibodies used were rabbit anti-PKCz (C-20) (1:250, Santa
Cruz Laboratories), mouse anti-Dlg (1:250, Developmental Studies Hybridoma
Bank [DSHB]), rat anti-E-cadherin (DCAD2) (1:100, DSHB), rabbit anti-BazCell Reports 22, 1639–1646, February 13, 2018 1643
(1:250, a gift from A. Wodarz), rabbit anti-pBazS980 (1:100, a gift from D. St
Johnston), and mouse anti-bPS (1:100, DSHB).
The secondary antibodies used were goat Alexa Fluor 488, 546, or 647
(1:500, Invitrogen); Phalloidin (2.5:250, Life Technologies) to stain F-actin;
and 40,6-diamidino-2-phenylindole (DAPI;1 mg/mL, Life Technologies) to visu-
alize nuclei.
Inhibitor Treatments in Ovaries
Wild-type egg chambers were cultured in imaging media containing
Schneider’s Media (Invitrogen), insulin (Sigma), heat-inactivated fetal calf
serum (FCS; GE Healthcare), trehalose (Sigma), adenosine deaminase
(Roche), methoprene (Sigma), and Ecdysone (Sigma) with either aPKC inhibi-
tor (0.01 mM, Cancer Research Technology CRT0066854 and CRT0103390),
Pak1 inhibitor (0.01mM,Sigma IPA3), or DMSO (Sigma) as a control for either 1
or 2 hr at room temperature. After treatment, samples were fixed and pro-
cessed normally for imaging.
In Vitro Kinase Assay
For in vitro kinase assays, high-pressure liquid chromatography (HPLC)-puri-
fied peptide substrates were incubated with either 150 pg recombinant human
Pak1 kinase domain (AbNOVA) or 0.1 mM recombinant human aPKCiota ki-
nase domain (a gift from N. McDonald) for 30 min at 30C in kinase reaction
buffer (250 mM HEPES [(4-(2- hydroxyethyl)-1-piperazineethanesulfonic
acid] pH 7.5, 50 mM MgCl2, 5 mM EGTA, 0.05% Brij35) containing 10 mM
cold ATP and 3 mCi Y-P32 ATP (PerkinElmer). Samples were blotted on P81
phosphocellulose paper (Millipore) and washed 3 3 10 min in 1% phosphoric
acid, then once in acetone. Incorporation of Y-P32 was quantified in counts
per minute by scintillation (Beckman LS 6500).
The peptides used in this study were as follows:
Crb VMARNKRATRGTYSPSA (1865.97 Da)
Baz EHFSRDALGRRSISEKHHAALD (2532.27 Da)
Par6 FDAEFRRWSFKRNEAEQ (2216.06 Da)
Lgl LSRRKSFKKSLRESFRKLR (2422.91 Da).
Peptides were diluted with deionized water to working dilutions (1 mg/mL)
and stored at 20C. Histone H1 (Millipore), a known substrate for Pak1,
was used as a control.
Mammalian Cell Culture and Transfection
Human Caco-2 adenocarcinoma colon cells were grown in DMEM (GIBCO
41966) containing L-glutamine and sodium pyruvate supplemented with
10%heat-inactivated FCS, 100 mg/mL streptomycin, and 100 mg/mL penicillin.
Cells were maintained in a 37C incubator at 5% atmospheric CO2. siRNA
transfections were performed using Lipofectamine RNAiMax transfection
reagent (Invitrogen) in antibiotic-free media. Briefly, cells were seeded in
6-well plates and treated with the siRNA/transfection mix 2 hr post-seeding.
A final concentration of 50–100 nM siRNA was used for transfection. Media
was changed the following morning and another round of siRNA transfection
was performed before the cells were trypsinised 4 hr later and reseeded
upon 10-mm coverslips in a 48-well plate. Cells were left for a total of 72 hr
before being processed for either immunofluorescence or immunoblotting.
The siRNA oligonucleotides targeted were as follows:
Pak1: 50-CAUCAAAUAUCACUAAGUC-30, 50-CAACAAAGAACAAUCA
CUA-30, 50-AGAAAUACCAGCACUAUGA-30, and 50-GUGAAAUGCUCUC
GGCUAU-30
aPKC: 50-GGGUACAGACAGAGAAGCAUU-30 and 50- GUGUUUGAGCA
GGCAUCCAUU-30
Cdc42: 50-CGGAAUAUGUACCGACUGU-30 and 50-GAUGACCCCUCUA
CUAUUG-30 or non-targeting control siRNAs (Thermo Fisher Scientific or
Sigma).
For the siRNA rescue experiment, Caco-2 cells were transfected with a sin-
gle siRNA oligonucleotide and left for 48 hr before being transfected with Rat
cDNA for 24 hr. Cells were fixed after 72 hr post-siRNA transfection. The Rat
cDNA was refractory to the human-specific siRNA oligos.1644 Cell Reports 22, 1639–1646, February 13, 2018Antibodies, Image Acquisition, and Quantification for Mammalian
Cell Culture
Cells were washed with 13 PBS and fixed, either in 4% paraformaldehyde in
PBS for 15min before permeabilising with 0.3%Triton X-100 in blocking buffer
(PBS containing 0.5% BSA, 10 mM glycine, and 0.1% sodium azide) or20C
methanol, for 5 min before quenching with PBS. Samples were then washed
and incubated in blocking buffer for 1 hr before staining. Primary and second-
ary antibodies were incubated in blocking buffer. Coverslips were mounted
using ProLong Antifade Reagent (Invitrogen).
The primary antibody used was mouse ZO-1 (Life Technologies); the
secondary antibodies were from Invitrogen, and used at 1:500 for 2 hr at
room temperature along with DAPI. Samples were imaged with a Leica SP5
confocal microscope and processed using Adobe Photoshop.
Quantification of ZO-1 staining in mammalian cell culture was scored as
either continuous, in which the junctional ZO-1 staining formed a complete
ring around the cell, or discontinuous, in which the ZO-1 staining was repeat-
edly broken or fragmented. Cells were assessed over three independent ex-
periments counting 400–700 cells per condition. For the rescue experiments,
the quantification of ZO-1 staining was assessed either in untransfected cells
using themethod outlined above or in transfected cells, scoring all of the trans-
fected cells and assessing the percentage. This was assessed over three inde-
pendent experiments counting 200–400 cells per condition. For 3D cultures,
the quantification was scored as either single lumen-containing cysts or
multi-lumen-containing cysts, assessed over three independent experiments
counting 100–200 cysts per experiment.
For 3D morphogenesis of Caco2 and MDCK cells, 8-well chambers (ibidi)
were coated with a layer of growth factor-reduced Matrigel (BD Biosciences)
and left to polymerize for 1 hr at 37C. Caco-2 cells were plated in low glucose
media with 2% Matrigel. After 48 hr, the medium was replaced with fresh me-
dium containing 2%Matrigel. Themedia was replaced with low glucosemedia
containing 2% Matrigel and 0.1 mg/mL cholera toxin 24 hr before fixation. The
next day, Pak1 and aPKC inhibitors were added for 8 hr at a concentration of
5 mM before being fixed with PFA and permeabilized for 5 min using a BSA/
SDS/Triton X-100 blocking solution (1% BSA, 0.1% NaN3, 20 mM glycine,
0.1%SDS, and 1%Triton X-100 in PBS). Samples were thenwashed and incu-
bated as described above.Wells were covered with 80%glycerol before being
imaged.
Statistical Analysis
Experiments were performed with at least three biological replicates. Prism
software was used to plot the mean of the experimental data, and error bars
represent the standard deviation. t Test for all of the conditions tested in this
article was found to be p < 0.01.
Inhibitor Treatment of Mammalian Tissue Culture
2Dmammalian inhibitor treatments weremaintained for 4 hr at a concentration
of 5 mM per inhibitor; 3D mammalian inhibitor treatments were carried out at
the same concentration for a period of 8 hr. siRNA and inhibitor treatments
were carried out with the same siRNA method, and on the day of fixation the
inhibitor was added for 4 hr, as described.
Animal Procedures
All animal-regulated procedures were carried out according to Project License
constraints (PPL 70/8560) and Home Office guidelines and regulations.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2018.01.060.
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